IP Library Granted Patent US 7,001,997
Granted Patent B2
US 7,001,997 · App. 10/251,482 · Granted Feb 21, 2006

Proteins, their production and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,001,997
App. No.
10/251,482
Granted
Feb 21, 2006
Kind
B2
Abstract

This invention relates to a novel metalloprotease having a proteolytic activity, its partial peptide or a salt either of them, a DNA coding for the protein, a recombinant vector comprising the DNA, a transformant carrying the recombinant vector, a process for producing the protein, a pharmaceutical composition comprising the DNA, an antibody against the protein, a method for screening for a compound which activates or inhibits a proteolytic activity of the protein, a kit for screening for the compound, and a compound which activates or inhibits a proteolytic activity of the protein which is identified by the screening method or the kit. The DNA coding for the protein of the present invention can be used as a therapeutic and prophylactic composition for a variety of diseases including diabetic nephropathy, glomerulonephritis, pulmonary fibrosis, hepatolienal fibrosis, hepatocirrhosis, osteopetrosis and herniated disk. Furthermore, the protein of the present invention is useful as a screening reagent for any compounds which activate or inhibit the function of the protein of the present invention. In addition, the antibody against the protein of the present invention specifically recognizes the protein of the present invention and can be used in the quantitative determination of the protein of the present invention in a test fluid.

Claims (14)

1. An isolated DNA comprising a DNA selected from the group consisting of:

(a) a DNA comprising a nucleotide sequence coding for a protein comprising the amino acid sequence set forth in SEQ ID NO: 1;

(b) a DNA comprising the nucleotide sequence set forth in SEQ ID NO: 7; and

(c) a DNA comprising a nucleotide sequence that hybridizes under stringent conditions comprising a salt concentration of 19 mM Na + and a temperature of 65° C. to the nucleotide sequence set forth in SEQ ID NO: 7 and that encodes a protein having a proteolytic activity that hydrolyzes casein.

2. The DNA according to claim 1 which contains a DNA comprising a nucleotide sequence coding for a protein comprising the amino acid sequence set forth in SEQ ID NO:1.

3. The DNA according to claim 1 , which comprises the nucleotide sequence set forth in SEQ ID NO: 7.

4. An isolated DNA which contains a DNA comprising a nucleotide sequence coding for a metalloprotease protein having the amino acid sequence set forth in SEQ ID NO: 1, or a salt thereof.

5. The isolated DNA according to claim 4 consisting of the nucleotide sequence set forth in SEQ ID NO: 7.

6. A recombinant vector comprising the DNA according to claim 1 .

7. A recombinant vector comprising the isolated DNA according to claim 4 .

8. A transformed host cell comprising the recombinant vector according to claim 6 .

9. A transformed host cell carrying the recombinant vector according to claim 7 .

10. A process for producing a protein encoded by the DNA according to claim 1 , or a salt thereof, which comprises culturing the transformed host cell according to claim 8 under conditions suitable for expression of said protein.

11. A process for producing a protein encoded by the DNA according to claim 4 , or a salt thereof, comprising culturing the transformed host cell of claim 9 under conditions suitable for the expression of the protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2007
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 019013/0140 →